Paper Details
- Home
- Paper Details
Antihistamines and other prognostic factors for adverse outcome in hyperemesis gravidarum.
Author: FejzoMarlena S, MacGibbonKimber, MagtiraAromalyn, MullinPatrick, RomeroRoberto, SchoenbergFrederic Paik, TabshKhalil
Original Abstract of the Article :
OBJECTIVE: The purpose of this study is to determine the frequency of adverse perinatal outcome in women with hyperemesis gravidarum and identify prognostic factors. STUDY DESIGN: This is a case-control study in which outcomes of first pregnancies were compared between 254 women with hyperemesis gr...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/23751910
データ提供:米国国立医学図書館(NLM)
Antihistamines and Adverse Outcomes in Hyperemesis Gravidarum
This study delves into the realm of pregnancy complications, specifically focusing on hyperemesis gravidarum (HG), a severe form of nausea and vomiting that can significantly impact pregnancy outcomes. The researchers conducted a case-control study, comparing pregnancy outcomes in women with HG to a control group of women with normal pregnancies. The study found that women with HG had a significantly higher risk of adverse outcomes, including preterm birth and lower birth weight. Interestingly, the study also found that the use of antihistamines was associated with increased risk of adverse outcomes, independent of the severity of HG. These findings raise concerns about the safety of antihistamine use during pregnancy, particularly in women with HG.
Antihistamine Use: A Potential Risk Factor for Adverse Outcomes
This study highlights the potential risks associated with antihistamine use during pregnancy, particularly in women with hyperemesis gravidarum (HG). The researchers found that antihistamine use was linked to an increased risk of adverse outcomes, including preterm birth and lower birth weight. These findings underscore the importance of carefully considering the risks and benefits of antihistamine use during pregnancy, especially for women with HG, and exploring alternative treatment options.
Implications for Pregnancy Care and Future Research
This research has significant implications for pregnancy care. The study's findings emphasize the need for clinicians to be aware of the potential risks associated with antihistamine use during pregnancy, particularly in women with HG. It also underscores the importance of exploring alternative treatment options for HG that may be safer for both mother and fetus. Further research is needed to better understand the mechanisms by which antihistamines may contribute to adverse pregnancy outcomes and to develop more effective and safer treatment strategies for HG.
Dr.Camel's Conclusion
Like a desert landscape where different species thrive, pregnancy is a complex journey with unique challenges. This study sheds light on the potential risks associated with antihistamine use during pregnancy, particularly for women with HG. It reminds us that even seemingly safe medications can have unexpected consequences. This research serves as a reminder to carefully consider all treatment options and to prioritize the well-being of both mother and child throughout the pregnancy journey.
Date :
- Date Completed 2014-06-02
- Date Revised 2021-10-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.